VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 229 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315 | -58.7% | 33,629 | +8.1% | 0.00% | -50.0% |
| Q2 2023 | $763 | +4.0% | 31,118 | -1.3% | 0.01% | 0.0% |
| Q1 2023 | $734 | -14.8% | 31,541 | -7.4% | 0.01% | -25.0% |
| Q4 2022 | $862 | -99.9% | 34,049 | +0.7% | 0.01% | +33.3% |
| Q3 2022 | $652,000 | -22.7% | 33,821 | +2.1% | 0.01% | -25.0% |
| Q2 2022 | $843,000 | +234.5% | 33,117 | +237.8% | 0.01% | +300.0% |
| Q1 2022 | $252,000 | -71.6% | 9,803 | -53.7% | 0.00% | -33.3% |
| Q4 2021 | $886,000 | +90.5% | 21,158 | +97.8% | 0.00% | -25.0% |
| Q3 2021 | $465,000 | -13.4% | 10,694 | -5.8% | 0.00% | 0.0% |
| Q2 2021 | $537,000 | +37.3% | 11,353 | +48.8% | 0.00% | -73.3% |
| Q1 2021 | $391,000 | +74.6% | 7,628 | -8.9% | 0.02% | +87.5% |
| Q4 2020 | $224,000 | -21.7% | 8,372 | +0.5% | 0.01% | -33.3% |
| Q3 2020 | $286,000 | -5.9% | 8,331 | +12.4% | 0.01% | -14.3% |
| Q2 2020 | $304,000 | – | 7,409 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |